Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Obesity Surgery|November 10, 2017
Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan StudyFelix Nickel, Christian Tapking, Laura Benner, et al.Expert Review of Hematology|September 29, 2016
How to facilitate early diagnosis of CNS involvement in malignant lymphomaAgnieszka Korfel, Martha Nowosielski, Javier Pardo-Moreno, et al.Blood|September 6, 2005
Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observationHermann Heimpel, Klaus Schwarz, Monika Ebnöther, et al.Haematologica|November 8, 2011
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyMichael Lübbert, Björn H Rüter, Rainer Claus, et al.Clinical Genitourinary Cancer|July 25, 2016
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient ProgramDimitrios Papazoglou, Luciano Wannesson, Dominik Berthold, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.Blood|April 28, 2006
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Nicola Goekbuget, et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|October 12, 2020
[German recommendations on lung and thoracic ultrasonography in patients with COVID-19]Daniel Kiefl, Stephan Eisenmann, Guido Michels, et al.British Journal of Haematology|December 17, 2016
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2<sup>nd</sup> -line therapy for relapsed and refractory multiple myeloma - a phase II trialUlrich J M Mey, Wolfram Brugger, Heike Schwarb, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survivalMax S Topp, Peter Kufer, Nicola Gökbuget, et al.Pageof 3